Johnson & Johnson

J&J MedTech Navigates Headwinds, Eyes Growth Surge in Second Half of 2024
J&J MedTech Navigates Headwinds, Eyes Growth Surge in Second Half of 2024
July 17, 2024  |  Healthcare

Johnson & Johnson’s (J&J) MedTech arm displayed resilience in its second quarter, navigating inflationary headwinds while prioritizing innovation. The unit, a key driver for J&J,...

READ MORE >
Robots Redefine Surgical Landscape for Enhanced Patient Outcomes
Robots Redefine Surgical Landscape for Enhanced Patient Outcomes
April 23, 2024  |  Healthcare

The integration of robotics is reshaping surgical procedures, promising enhanced precision, efficiency, and improved patient outcomes.  Recent earnings reports from industry giants like Intuitive Surgical and Johnson &...

READ MORE >
Johnson & Johnson Amplifies MedTech Profile in Q1 Earnings
Johnson & Johnson Amplifies MedTech Profile in Q1 Earnings
April 16, 2024  |  Earnings

Johnson & Johnson (J&J) has emphasized the pivotal role of medical technology (MedTech) in advancing healthcare. During a Tuesday (April 16) call with analysts to discuss...

READ MORE >
J&J Sees Surge in MedTech Sales Post-Kenvue Split 
J&J Sees Surge in MedTech Sales Post-Kenvue Split 
January 23, 2024  |  Healthcare

Six months after parting ways with its consumer health unit, Kenvue, Johnson & Johnson has reported total sales of $21.4 billion for the last quarter of...

READ MORE >
J&J’s Medical Device Sales Feel the Side Effects of Weight-Loss Drugs 
J&J’s Medical Device Sales Feel the Side Effects of Weight-Loss Drugs 
October 17, 2023  |  Healthcare

Riding high, Johnson & Johnson reported pharmaceutical sales worth $13.89 billion on Tuesday (Oct 17), a year-over-year growth exceeding 5%.  The pharmaceuticals driving its growth...

READ MORE >
Tylenol Maker Kenvue Sees Self-Care Surge as Amazon Emerges as Destination for Category
Tylenol Maker Kenvue Sees Self-Care Surge as Amazon Emerges as Destination for Category
July 20, 2023  |  Earnings

Despite beating second-quarter revenue and earnings expectations in its first quarterly report since spinning out from Johnson & Johnson two months ago, Kenvue’s shares declined...

READ MORE >
Johnson & Johnson Spinoff Kenvue Valued at $41 Billion in IPO
Johnson & Johnson Spinoff Kenvue Valued at $41 Billion in IPO
May 04, 2023  |  IPO

Johnson & Johnson’s consumer healthcare spinoff has made the biggest U.S. initial public offering (IPO) since 2021. Kenvue, which includes Band-Aid and several other well-known...

READ MORE >
Johnson & Johnson Prepares to Test IPO Waters
Johnson & Johnson Prepares to Test IPO Waters
April 23, 2023  |  IPO

Johnson & Johnson is reportedly readying an investors roadshow to take its commercial healthcare unit public. According to a Sunday (April 23) Wall Street Journal...

READ MORE >
Johnson & Johnson Focuses on Robotic Surgery as Elective Procedures Climb
Johnson & Johnson Focuses on Robotic Surgery as Elective Procedures Climb
April 18, 2023  |  Earnings

As Johnson & Johnson readies for the separation of its consumer health division later this year into the consumer-focused company called Kenvue, the healthcare giant’s...

READ MORE >